USPTO Deadlines
Next Deadline
1749 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20241008)
Due Date
October 08, 2030
Grace Period Ends
April 08, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 24, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| May 6, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| May 6, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Nov 7, 2024 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Oct 8, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 23, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 3, 2024 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jun 15, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 7, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 19, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Dec 15, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 14, 2023 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Dec 7, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of ulcerative colitis; antidiabetic preparations; human vaccine preparations; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; anti-inflammatory preparations; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of diseases of the metabolic system; medicated pharmaceutical preparations for skin treatment; pharmaceutical preparations for psoriasis treatment; pharmaceutical preparations for the treatment of psoriatic arthritis; pharmaceutical preparations for the treatment of crohn's disease; dietary supplements
Classification
International Classes
005